Azathioprine Prescribing in Neurology

Overview

Journal J Neurol

Specialty Neurology

Date 2008 May 16

PMID 18481037

Citations 1

Authors

P Goldsmith

G Lennox

N Bhalla

Affiliations

Soon will be listed here.

Citing Articles

Low-level laser reduces the production of TNF-α, IFN-γ, and IL-10 induced by OVA.

Oliveira R, Ferreira A, Cortes A, Aarestrup B, Andrade L, Aarestrup F Lasers Med Sci. 2013; 28(6):1519-25.

PMID: 23337926 DOI: 10.1007/s10103-012-1262-5.

References

van Schaik I, Bouche P, Illa I, Leger J, Van den Bergh P, Cornblath D . European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol. 2006; 13(8):802-8. DOI: 10.1111/j.1468-1331.2006.01466.x. View

Anstey A, Wakelin S, Reynolds N . Guidelines for prescribing azathioprine in dermatology. Br J Dermatol. 2004; 151(6):1123-32. DOI: 10.1111/j.1365-2133.2004.06323.x. View

ODonovan P, Perrett C, Zhang X, Montaner B, Xu Y, Harwood C . Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005; 309(5742):1871-4. PMC: 2426755. DOI: 10.1126/science.1114233. View

Silman A, Petrie J, Hazleman B, Evans S . Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. Ann Rheum Dis. 1988; 47(12):988-92. PMC: 1003651. DOI: 10.1136/ard.47.12.988. View

Kandiel A, Fraser A, Korelitz B, Brensinger C, Lewis J . Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005; 54(8):1121-5. PMC: 1774897. DOI: 10.1136/gut.2004.049460. View

Hoover R, Fraumeni Jr J . Risk of cancer in renal-transplant recipients. Lancet. 1973; 2(7820):55-7. DOI: 10.1016/s0140-6736(73)93256-x. View

Agbogu B, STERN B, Sewell C, Yang G . Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol. 1995; 52(9):875-9. DOI: 10.1001/archneur.1995.00540330053014. View

Newsom-Davis J . Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome. Semin Neurol. 2003; 23(2):191-8. DOI: 10.1055/s-2003-41135. View

Knowles S, Gupta A, Shear N, Sauder D . Azathioprine hypersensitivity-like reactions--a case report and a review of the literature. Clin Exp Dermatol. 1995; 20(4):353-6. DOI: 10.1111/j.1365-2230.1995.tb01343.x. View

10.

Confavreux C, Saddier P, Grimaud J, Moreau T, Adeleine P, AIMARD G . Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology. 1996; 46(6):1607-12. DOI: 10.1212/wnl.46.6.1607. View

11.

Marra C, Esdaile J, Anis A . Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. J Rheumatol. 2002; 29(12):2507-12. View

12.

Taylor L, Hughes R, McPherson K . The risk of cancer from azathioprine as a treatment for multiple sclerosis. Eur J Neurol. 2004; 11(2):141. DOI: 10.1046/j.1351-5101.2003.00721.x. View

13.

Palace J, Newsom-Davis J, Lecky B . A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group. Neurology. 1998; 50(6):1778-83. DOI: 10.1212/wnl.50.6.1778. View

14.

Mastaglia F, Zilko P . Inflammatory myopathies: how to treat the difficult cases. J Clin Neurosci. 2002; 10(1):99-101. DOI: 10.1016/s0967-5868(02)00271-0. View

15.

Confavreux C, Vukusic S . Non-specific immunosuppressants in the treatment of multiple sclerosis. Clin Neurol Neurosurg. 2004; 106(3):263-9. DOI: 10.1016/j.clineuro.2004.02.012. View

16.

Meggitt S, Gray J, Reynolds N . Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet. 2006; 367(9513):839-46. DOI: 10.1016/S0140-6736(06)68340-2. View